Monon Bioventures Receives Nearly $400,000 To Develop Purdue-Discovered Glioblastoma Treatment Oct 28 Written by Glioblastoma Research Glioblastoma Research Previous Previous UC Brain Tumor Center Hosts Clinical Research Retreat Next Next UCLA Researchers Identify Gene As Potential Target In Treatment-Resistant Brain Cancer
Monon Bioventures Receives Nearly $400,000 To Develop Purdue-Discovered Glioblastoma Treatment Oct 28 Written by Glioblastoma Research Glioblastoma Research
